Renaissance Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Renaissance Pharmaceuticals's estimated annual revenue is currently $19.5M per year.(i)
  • Renaissance Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Renaissance Pharmaceuticals has 97 Employees.(i)
  • Renaissance Pharmaceuticals grew their employee count by -8% last year.

Renaissance Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.3M617%N/AN/A
#2
$354.3M461-2%$567.1MN/A
#3
$377.1M1876-1%N/AN/A
#4
$7.8M398%N/AN/A
#5
$5.4M270%N/AN/A
#6
$45M2246%N/AN/A
#7
$6.8M34-82%N/AN/A
#8
$9.2M4612%N/AN/A
#9
N/A69446%N/AN/A
#10
$15.5M775%N/AN/A
Add Company

What Is Renaissance Pharmaceuticals?

Renaissance Pharmaceuticals is a pharmaceuticals company based out of 17 Battery Pl Rm 306, New York, New York, United States.

keywords:N/A

N/A

Total Funding

97

Number of Employees

$19.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Renaissance Pharmaceuticals News

2022-04-20 - Brokerages Anticipate NeuroBo Pharmaceuticals, Inc ...

Equities research analysts expect NeuroBo Pharmaceuticals, ... Renaissance Technologies LLC acquired a new stake in shares of NeuroBo...

2022-04-20 - Diffusion Pharmaceuticals (DFFN) – Investment Analysts ...

Renaissance Technologies LLC now owns 1,223,102 shares of the company's stock valued at $373,000 after acquiring an additional 97,600 shares...

2022-04-17 - Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) Sees Significant ...

Renaissance Technologies LLC owned approximately 8.53% of Quoin Pharmaceuticals as of its most recent filing with the Securities & Exchange...

2019-09-03 - Migraine biotech Satsuma Pharmaceuticals sets terms for $75 ...

Satsuma Pharmaceuticals, a clinical-stage biotech developing a therapy for ... Renaissance Capital's Renaissance IPO ETF (symbol: IPO) ...

2019-09-03 - Digging Up the Details on Pieris Pharmaceuticals, Inc. (PIRS)

On Friday, shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) marked ... In the meanwhile, Renaissance Technologies LLC also increased ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.8M9711%N/A
#2
$23.6M97-5%N/A
#3
$12.6M97-3%$13.8M
#4
$24.6M9710%N/A
#5
$26.2M978%N/A